Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gauthier S., Panisset M., Nalbantoglu J., Poirier J. Alzheimer's disease: current knowledge, management and research. CMAJ. 1997 Oct 15;157(8):1047–1052. [PMC free article] [PubMed] [Google Scholar]
- Hux M. J., O'Brien B. J., Iskedjian M., Goeree R., Gagnon M., Gauthier S. Relation between severity of Alzheimer's disease and costs of caring. CMAJ. 1998 Sep 8;159(5):457–465. [PMC free article] [PubMed] [Google Scholar]
- Rogers S. L., Doody R. S., Mohs R. C., Friedhoff L. T. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998 May 11;158(9):1021–1031. doi: 10.1001/archinte.158.9.1021. [DOI] [PubMed] [Google Scholar]
- Rogers S. L., Farlow M. R., Doody R. S., Mohs R., Friedhoff L. T. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998 Jan;50(1):136–145. doi: 10.1212/wnl.50.1.136. [DOI] [PubMed] [Google Scholar]
- Rogers S. L., Friedhoff L. T. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study. Eur Neuropsychopharmacol. 1998 Feb;8(1):67–75. doi: 10.1016/s0924-977x(97)00079-5. [DOI] [PubMed] [Google Scholar]
- Rogers S. L., Friedhoff L. T. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia. 1996 Nov-Dec;7(6):293–303. doi: 10.1159/000106895. [DOI] [PubMed] [Google Scholar]